Latest NewsMay 9, 2019

Orgenesis First Quarter 2019 Revenue Increases 177% to a Record $7.3 Million

Recent News

Apr 30, 2019
Orgenesis Announces Planned Study to Confirm Suitability of Liver Cells as a Source for Personalized Cell Replacement Therapy for Insulin-Dependent Diabetic Patients
Apr 22, 2019
Orgenesis Announces Collaboration Agreement with Columbia University to Develop Cellular Vaccination Product Platform for Pancreatic, Hepatic and Cholangiocarcinoma Cancers
Apr 11, 2019
Orgenesis Announces Collaboration and License Agreement for Exosome-Related Technologies with ExcellaBio
Apr 4, 2019
Orgenesis Announces Collaboration with Digilab to Develop Industrial 3D Printing Capability for Cellular Structures and Tissues for Clinical Use
View All Press Releases

Latest EventFeb 12, 2019 • 9:00am EDT

2019 BIO CEO & Investor Conference
View All Events